Research Studies

‘Chill Packs’: Evaluating Self-Administered Olanzapine as a Psychiatric Harm Reduction Intervention to Prevent Methamphetamine-Induced Psychosis
2025-2026 | Co-Investigator, Mentor
UC San Diego Health Community Psychiatry Research Program
PI: Joseph Friedman, M.D., Ph.D.

REACH: Recognizing and Eliminating Disparities in Addiction through Culturally Informed Healthcare — Minority Fellowship Program

2024-2025 | Sub-Principal Investigator
NIH/NIDA; AAAP: 6H79TI081358-05

Sub-PI: Carla Marienfeld, M.D., c/o Claudin Gomez, M.D.

REACH: Recognizing and Eliminating Disparities in Addiction through Culturally Informed Healthcare

2023-2024 | Principal Investigator
NIH/NIDA: Sub MFG-2022-6 (H79TI081358)

PI: Carla Marienfeld, M.D., c/o Nancy McGinley, M.D.

Sex Differences in Neurobiological Mechanisms of Alcohol Sensitivity and Tolerance
2022-2025 | Co-Principal Investigator
NIH/NIAAA: R33AA027634-03
Co-PI: Robert Anthenelli, M.D.

Clinical Development of an mGlu2 Positive Allosteric Modulator for Nicotine Addiction
2020-2023 | Co-Investigator
NIH/NIDA via Sanford Burnham: U01DA051077-01
PI: Nicholas Cosford, Ph.D.

Sex Differences in Neurobiological Mechanisms of Alcohol Sensitivity and Tolerance

2020–2022 | Co-Principal Investigator
NIH/NIAAA: R21AA027634-01A1
Co-PI: Robert Anthenelli, M.D.

Predicting Infection Outcomes Using Nongenetic Differences in Brain Structure

2020–2021 | Co-Investigator
Kavli Institute for Brain and Mind Innovative Research Grant
PI: Robert Gallant, Ph.D.

Addiction Scientists Strengthened through Education and Training (ASSET)

2020-2025 | Co-Principal Investigator, Mentor
NIH/NIDA: 1R25DA050724-01A1
PD/PIs: Eileen Virtusio Pitpitan, Ph.D.; Maria Luisa Zuniga de Nuncio, Ph.D.

Novel Pharmacotherapy Approaches for Smokers with Serious Mental Illness

2019-2022 | Co-Principal Investigator
UC Tobacco-Related Disease Research Program: T29IP0379
Co-PI: Robert Anthenelli, M.D.

Preclinical Development of Selective mGlu2 Positive Allosteric Modulators for Substance Use Disorders

2017–2020 | Statistician
NIH/NIDA via Sanford Burnham: U01DA041731
PI: Nicholas Cosford, Ph.D.

Lorcaserin for the Treatment of Cocaine Use Disorder

2017–2019 | Co-Principal Investigator, San Diego Site
NIDA/VA Cooperative Study #1033
San Diego Site PI: Robert Anthenelli, M.D.
Overall PI: Shwe Gyaw, M.D.

Weight Gain Associated with ALKS 3831 Compared with Olanzapine in Adults with Schizophrenia

2016–2018 | Co-Investigator
Alkermes, Inc.
San Diego Site PI: Robert Anthenelli, M.D.

AZD8529 for Smoking Cessation in Female Smokers

2015–2017 | Co-Investigator, San Diego Site
NIDA/VA Cooperative Study #1032
San Diego Site PI: Robert Anthenelli, M.D.
Overall PI: David McCann, Ph.D.

Stress Reactivity as a Predictor of Relapse in Patients with Alcohol Use Disorder and PTSD

2015–2017 | Co-Principal Investigator
INIA Stress Pilot Project, NIAAA through Oregon Health & Science University
Co-PI: Robert Anthenelli, M.D.
Overall PI: Kathleen Grant, Ph.D.

Wearable Biosensors for Real-Time Blood Alcohol Monitoring

2015–2019 | Co-Investigator
NIH/NIAAA: 1R44AA02463-01
Co-PIs: Robert Anthenelli, M.D.; Joshua Ray Windmiller, Ph.D.; Joseph Wang, D.Sc.

Sleep and Circadian Function in Working Memory Deficits in Euthymic Bipolar Disorder

2012–2013 | Principal Investigator
Veterans Affairs Mental Illness Research, Education, and Clinical Center

VISN 22 Pala Grant

Neural Mechanisms of Sleep-Dependent Memory Consolidation

2009–2011 | Co-Investigator
UC San Diego Chancellor’s Interdisciplinary Collaboratories Program Grant
PI: Denise Cai, Ph.D.